Management of Schatzki Ring
Symptomatic Schatzki rings should be treated with a combination of endoscopic dilatation to 16-20 mm followed by long-term proton pump inhibitor (PPI) therapy to prevent recurrence. 1
Diagnosis and Clinical Presentation
Schatzki's ring is an annular constriction at the gastroesophageal junction characterized by:
- Located at the squamocolumnar junction (proximal side covered by squamous epithelium, distal by gastric mucosa)
- Common finding in 6-14% of barium swallow examinations
- Often causes intermittent dysphagia for solids and food bolus obstruction
- According to "Schatzki's rule," dysphagia is typically present with ring diameters ≤13 mm and rarely occurs with diameters >20 mm 1
Management Algorithm
Step 1: Determine if intervention is needed
- Asymptomatic rings: No dilatation needed for incidentally discovered asymptomatic Schatzki rings 1
- Symptomatic rings: Proceed with treatment if patient presents with dysphagia or food impaction
Step 2: Initial therapeutic approach
- First-line treatment options:
Step 3: Post-dilatation management
- Initiate PPI therapy: Long-term PPI therapy (e.g., omeprazole 20 mg/day) significantly reduces the risk of relapse compared with placebo for up to 48 months 1
Step 4: Management of recurrent symptoms
- For recurrence after dilatation:
Evidence-Based Considerations
Effectiveness of PPI Therapy
- PPI therapy after dilatation significantly reduces the risk of relapse of Schatzki's ring 1
- Recent research shows that acid suppression medication alone can be effective, with significant improvements in ring lumen diameter (median increase from 10mm to 15mm) and ability to pass food 2
Alternative Treatment Options
- Electrosurgical incision: At least as effective as single large calibre dilatation in randomized trials 1
- Provides longer dysphagia-free intervals compared to repeated bougienage (17 months vs. 5 months) 3
- Biopsy excision: Complete obliteration with jumbo cold biopsy forceps was effective and safe in a small feasibility study of 10 patients, with improvement persisting during a mean follow-up of 379 days 4
Important Considerations and Caveats
Rule out eosinophilic esophagitis: Consider obtaining distal, mid, and proximal esophageal biopsies in symptomatic Schatzki's ring to exclude eosinophilic esophagitis 1
Association with GERD: Schatzki's ring is associated with gastroesophageal reflux, which may explain why PPI therapy reduces recurrence rates 1, 5
Medication history: Some patients without proven reflux may have Schatzki's ring related to chronic ingestion of medications known to damage esophageal mucosa 5
Response to treatment: Patients without reflux may respond better to a single dilatation (62%) compared to those with reflux (37%) 5
Treatment selection: The therapeutic approach should consider the presence or absence of reflux, as this may influence treatment response and recurrence rates 1, 5